VIVO Cannabis Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • VIVO Cannabis's estimated annual revenue is currently $4.7M per year.(i)
  • VIVO Cannabis's estimated revenue per employee is $189,000

Employee Data

  • VIVO Cannabis has 25 Employees.(i)
  • VIVO Cannabis grew their employee count by -29% last year.

VIVO Cannabis's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Director Financial Planning And AnalysisReveal Email/Phone
3
Director, Commercial PlanningReveal Email/Phone
4
Director Process OptimizationReveal Email/Phone
5
Senior Manager, Customer CareReveal Email/Phone
6
Commercial Analytics and InsightsReveal Email/Phone
7
Independent Commercial Strategy and Analytics ConsultantReveal Email/Phone
8
Quality Assurance SpecialistReveal Email/Phone
9
Financial ControllerReveal Email/Phone
10
Accounting ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.4M53-59%$9.2MN/A
#2
$149.5M4437%N/AN/A
#3
$153.6M4552%N/AN/A
#4
$10.6M499%N/AN/A
#5
N/A0N/A$7.7MN/A
#6
$3.8M205%N/AN/A
#7
$144.1M4275%N/AN/A
#8
$21.1M78-20%N/AN/A
#9
$568.6M1116-17%$4.5BN/A
#10
$65.6M2213%N/AN/A
Add Company

What Is VIVO Cannabis?

VIVO Cannabis is changing the way people view cannabis. Throughout the world, there continues to be increasing acceptance and recognition of cannabis-based therapies for health and healing. VIVO?s products and services focus on helping patients and consumers achieve their wellness objectives and positively impact quality of life. VIVO holds production and sales licences from Health Canada at its facilities in Napanee, ON, and Hope, BC. VIVO is expanding its production capacity and pursuing partnership and product development opportunities domestically, and in select international markets. From seed to sale, VIVO is a family of premium products and services developed to meet the needs of both medical and adult-use consumers. VIVO?s portfolio includes the following brands: Canna Farms ? cannafarms.ca ? B.C.?s first, B.C?s finest. As BC?s first licensed producer of cannabis, Canna Farms embraces the rich cannabis culture and cultivation history that Canada and British Columbia are known for to produce a large selection of award-winning cannabis flowers and oils. Beacon Medical ? beaconmedical.ca ? The Clear Path to Medical Cannabis. Standardized pharma-grade cannabis produced in small-batch, precisely controlled cultivation rooms. Beacon Medical products are clean and consistent ? qualities sought after by both patients and physicians. Fireside ? firesidecannabis.com ? Tell Your Story, Fireside. Premium adult-use cannabis grown in small batches with a long curing process to ensure a smooth final product in three varieties. Lumina Wellness ? luminawellness.com ? Wellness, Elevated. An elegantly designed wellness-focused adult-use cannabis product line to elevate your self-care routine. Harvest Medicine ? hmed.ca ? Assessment. Education. Support. Harvest Medicine is an established medical cannabis clinic with six locations across four provinces. The clinics provide high-quality primary data to steer product development and treatment plans.

keywords:N/A

N/A

Total Funding

25

Number of Employees

$4.7M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

VIVO Cannabis News

2022-04-17 - White House, pressed to free cannabis prisoners, touts ...

A study found that “the majority of patients experience decreased fatigue from consumption of cannabis flower consumed in vivo.”

2022-04-17 - Cannabis Market Size And Forecast | Aurora Cannabis Inc ...

Aurora Cannabis Inc., Aphria Inc., Canopy Growth Corporation, Chronos Group Inc., Vivo Cannabis Inc., Terra Tech Corp., Medmen, Stenocare, Tikun...

2022-03-30 - VIVO Cannabis Announces Fourth Quarter 2021 Results

March 31, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“) today released its fourth quarter 2021 financial...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.5M25-17%N/A
#2
$2.5M25-32%N/A
#3
$4.3M25-29%N/A
#4
$2.5M25N/AN/A
#5
$1.7M25N/AN/A